Few drug labeling changes result from neonate studies

12/10/2013 | Family Practice News

Despite federal legislation that encourages pediatric drug research in the U.S., researchers found that only 11 of 24 neonatal drug labeling changes between 1997 and 2010 confirmed the drug's safety and effectiveness for newborns. Of the 28 drugs included in neonatal studies, almost half were not not used in neonatal intensive care units and almost a third of them were used in less than 60 babies. The findings were published in the journal JAMA Pediatrics.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA